Phase 3 Type 2 Diabetes Mellitus (T2DM) Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of BGM0504 in Participants with Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.537 enrolled1 locationNCT06716216
Recruiting
Phase 3
A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.207 enrolled1 locationNCT06716203
Recruiting
Phase 3
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Type 2 Diabetes Mellitus (T2DM)Diabetes Mellitus in PregnancyGestational Diabetes Mellitus, Class A2
Loyola University160 enrolled1 locationNCT06619301